ImmunityBio Stock (IBRX) Rockets Higher after Reporting 700% Growth in Anktiva Sales - TipRanks
ImmunityBio ($IBRX) stock surged over 30% on Thursday after the company released preliminary 2025 results, which pointed to a 700% jump in Anktiva sales. The biotechnology company reported about $113